| Alemtuzumab studied in …STUDIED_INderived141 of 141show fewer |
|---|
| → studied in | NCT06084780Phase 2 · not yet recruiting Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) · 141 trials list this drug (5 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04696731Phase 1 · active not recruiting Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04093596Phase 1 · completed Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) · 141 trials list this drug (5 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03821610Phase 2 · active not recruiting A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC) · 141 trials list this drug (5 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02711202NA · completed Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04416984Phase 1/Phase 2 · active not recruiting Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2) · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03939026Phase 1 · completed Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714345Phase 2 · terminated Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625351Phase 1 · completed A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas · 141 trials list this drug (5 active) | — | — | Digestive System Neoplasm,Germ Cell Tumor,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361711Phase 2 · active not recruiting Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06705608completed Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study · 141 trials list this drug (5 active) | — | — | Malignant Skin Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989466Phase 1 · completed Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05000450Phase 1/Phase 2 · terminated Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma · 141 trials list this drug (5 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02061800Phase 1/Phase 2 · unknown CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant · 141 trials list this drug (5 active) | — | — | Lymphoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02385110Phase 2 · completed Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047060Phase 1/Phase 2 · completed Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome · 141 trials list this drug (5 active) | — | — | Mycosis Fungoides,Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00074282Phase 2 · completed Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013961Phase 2 · terminated Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006390Phase 2 · completed Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256398Phase 2 · completed Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 141 trials list this drug (5 active) | — | — | Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00199030Phase 2 · completed Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath · 141 trials list this drug (5 active) | — | — | Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01030900Phase 2 · completed Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas · 141 trials list this drug (5 active) | — | — | Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01982175Phase 2 · suspended Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061945Phase 1/Phase 2 · completed Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia · 141 trials list this drug (5 active) | — | — | Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00345345Phase 2 · completed Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689453Phase 1 · completed Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) · 141 trials list this drug (5 active) | — | — | Adult T-Cell Leukemia/Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,T-Cell Prolymphocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00951457Phase 1/Phase 2 · completed Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL) · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00069238Phase 2 · completed Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas · 141 trials list this drug (5 active) | — | — | T-Cell Non-Hodgkin Lymphoma,Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01186640Phase 2 · completed Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) · 141 trials list this drug (5 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02497404Phase 2 · completed Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR · 141 trials list this drug (5 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059239Phase 1/Phase 2 · completed Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma · 141 trials list this drug (5 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00858117Phase 2 · completed A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536978Phase 2 · completed Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00983528Phase 1/Phase 2 · terminated Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia · 141 trials list this drug (5 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01269385Phase 1/Phase 2 · completed Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00578292NA · terminated Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00566696Phase 2 · completed Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00562328Phase 2 · completed Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01596699Phase 2 · terminated Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00553098Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040846Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies · 141 trials list this drug (5 active) | — | — | Anaplastic Large Cell Lymphoma,Hairy Cell Leukemia,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368355Phase 2 · completed T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts · 141 trials list this drug (5 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00048412Phase 1/Phase 2 · completed Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H · 141 trials list this drug (5 active) | — | — | Leukemia,Multiple Myeloma,Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00057005Phase 1 · completed Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085449Phase 1/Phase 2 · withdrawn Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01392079Phase 2 · completed Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01875237Phase 1/Phase 2 · terminated Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene · 141 trials list this drug (5 active) | — | — | Leukemia,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801931Phase 1/Phase 2 · terminated Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520130Phase 1/Phase 2 · completed Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System · 141 trials list this drug (5 active) | — | — | Acute Leukemia,Hodgkin Lymphoma,Multiple Myeloma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00057967Phase 2 · completed Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943319Phase 1/Phase 2 · completed Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132584Phase 1 · terminated Cyclophosphamide and Alemtuzumab In Lymphoma · 141 trials list this drug (5 active) | — | — | Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,High Grade B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00129753Phase 2 · withdrawn Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease · 141 trials list this drug (5 active) | — | — | Lymphoma,Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038883NA · terminated Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies · 141 trials list this drug (5 active) | — | — | B-Cell Malignant Neoplasm,Leukemia,Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278213Phase 2 · completed Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565981Phase 2 · completed A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301834Phase 2 · completed Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders · 141 trials list this drug (5 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416884Phase 2 · terminated Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00935792Phase 1/Phase 2 · completed Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 141 trials list this drug (5 active) | — | — | Lymphoid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02653196early Phase 1 · terminated A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors · 141 trials list this drug (5 active) | — | — | Solid Neoplasm,Neuroepithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281983Phase 1/Phase 2 · completed Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118352Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · 141 trials list this drug (5 active) | — | — | Anaplastic Large Cell Lymphoma,Hairy Cell Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00555048Phase 1/Phase 2 · terminated Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer · 141 trials list this drug (5 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01191749Phase 2 · terminated Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL) · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00698685Phase 2 · terminated Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation · 141 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00143065Phase 2 · completed Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00323323Phase 1 · completed CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas · 141 trials list this drug (5 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104975Phase 1 · completed Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00637390Phase 1 · terminated A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. · 141 trials list this drug (5 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00683046Phase 2 · completed T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies · 141 trials list this drug (5 active) | — | — | Lymphoma,Hodgkin Lymphoma,Lymphoid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058825Phase 1/Phase 2 · terminated Stem Cell Transplant for Hematologic Diseases · 141 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00276809Phase 2 · completed Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00046683Phase 3 · completed Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004857Phase 2 · completed Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00775632Phase 2 · completed Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00330252Phase 1 · completed Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00579111Phase 1/Phase 2 · terminated Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) · 141 trials list this drug (5 active) | — | — | Acute Lymphoblastic Leukemia,Multiple Myeloma,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00578539NA · terminated T-Reg Cell Kinetics, Stem Cell Transplant, REGALE · 141 trials list this drug (5 active) | — | — | Leukemia,Hodgkin Lymphoma,Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00578903Phase 2 · terminated Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01518153Phase 2 · terminated Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00587847NA · terminated Campath Maintenance in Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00871546Phase 2 · terminated SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715) · 141 trials list this drug (5 active) | — | — | Leukemia,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00771602Phase 2 · terminated Alemtuzumab + Rituximab Consolidation in CLL · 141 trials list this drug (5 active) | — | — | Leukemia,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453427Phase 1/Phase 2 · completed Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas · 141 trials list this drug (5 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00262925Phase 2 · terminated Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia · 141 trials list this drug (5 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923182Phase 1 · completed A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077961Phase 1/Phase 2 · terminated Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL · 141 trials list this drug (5 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00051701Phase 1/Phase 2 · terminated Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma · 141 trials list this drug (5 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00781781Phase 2 · terminated Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00073879NA · completed Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation · 141 trials list this drug (5 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00230282Phase 2 · completed Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia,Chronic Leukemia,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669318Phase 2 · completed Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098670Phase 2 · completed Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943293Phase 1 · terminated Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies · 141 trials list this drug (5 active) | — | — | Lymphoma,Multiple Myeloma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00328198Phase 2 · completed Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943592Phase 1/Phase 2 · completed Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies · 141 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113048Phase 1 · terminated Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies · 141 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021151NA · completed Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00818961Phase 2 · terminated Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00836043terminated Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274976Phase 2 · completed Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00363090Phase 1/Phase 2 · unknown Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462332Phase 2 · completed Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454480Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 141 trials list this drug (5 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00562068Phase 1 · unknown Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma · 141 trials list this drug (5 active) | — | — | Lymphoma,Small Intestinal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00947388Phase 1 · terminated Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458523Phase 2 · completed Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895739Phase 2 · unknown Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086775Phase 2 · completed Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720447Phase 2 · unknown Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00907036Phase 2 · unknown Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00908180Phase 2 · unknown Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00564512Phase 3 · completed Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089349Phase 2 · completed Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia · 141 trials list this drug (5 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806337Phase 2 · completed CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma · 141 trials list this drug (5 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00525603Phase 2 · completed CFAR Study in Patients With Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081068Phase 2 · withdrawn Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027560Phase 2 · completed Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00142181Phase 2 · completed Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia · 141 trials list this drug (5 active) | — | — | Lymphoplasmacytic Lymphoma,Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061048Phase 2 · completed Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma · 141 trials list this drug (5 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00069992Phase 2 · terminated Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML · 141 trials list this drug (5 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00071396Phase 2 · completed Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453193Phase 2 · terminated Alemtuzumab and Pentostatin In T-cell Neoplasms · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00102661Phase 2 · completed Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00056966Phase 1/Phase 2 · completed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases · 141 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00725231Phase 3 · unknown Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP · 141 trials list this drug (5 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01082939Phase 2 · completed Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00525876NA · completed Non-Myeloablative Allogeneic Stem Cell Transplantation · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436904Phase 2 · completed Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00505921Phase 2 · terminated Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma · 141 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00930605Phase 2 · completed The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL) · 141 trials list this drug (5 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00109993Phase 2 · completed Campath-1H + FK506 and Methylprednisolone for GVHD · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Malignant Breast Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00410657Phase 2 · completed Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant · 141 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Malignant Breast Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00292760Phase 2 · completed A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00441025Phase 2 · terminated The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL · 141 trials list this drug (5 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00337519Phase 2 · unknown Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00800943Phase 2 · unknown Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458250Phase 1 · completed Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H · 141 trials list this drug (5 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00162851Phase 2 · completed Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00157274Phase 2 · unknown Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome · 141 trials list this drug (5 active) | — | — | Mycosis Fungoides,Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336206NA · unknown Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia · 141 trials list this drug (5 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |